StockTipsArenaBeta

BUY Shilpa Medicare Limited — Prabhudas Lilladher

BUYShilpa Medicare Limited
Shilpa Medicare share price target & all analyst calls

byPrabhudas LilladherHorizon: NA (inferred 1–3 months)30 Oct 2026via LiveMint Markets

Entry₹957Inferred
Target₹1,230
Total upside +28.53%
Stop loss₹765-20.06% risk
CMP₹942.351d ago
Active-1.53%+30.52%upside left 3 mo left
Follow Prabhudas Lilladher for new calls(36% target hit, 14 closed calls)Get alertsWatch SHILPAMED for new buy/sell callsGet alertsSee 74 other Short-term picks this week

Not investment advice; past performance doesn't guarantee future results. · Public beta — data is auto-extracted and may contain errors.

AI Assessment

Automated market context for this BUY call — facts from public sources, machine-classified. Not investment advice.

As of 7 Nov, 5:27 pm IST
5 supporting1 neutral0 opposing
Supports the BUY call (5)

MACD above its signal line — bullish momentum

Technicals · macd·7 Nov · today

3 advisors have active long-term BUY calls on this stock, with 2 issued in the last 14 days

Advisor consensus · adjacent horizon·6 Nov · yesterday

Shilpa Medicare Q2 results: Net profit jumps 80%, revenue rises 43%

NewsCnbc-Tv18·5 Nov · 2d ago

(opens in new tab)

Dr Reddy's stock could rise 10-15% if a major biosimilar gets approved in December: Systematix

NewsCnbc-Tv18·27 Oct · 2w ago

(opens in new tab)

AGES Austria issues GMP certification to Shilpa Medicare’s Jadcherla unit

NewsCnbc-Tv18·10 Oct · 4w ago

(opens in new tab)
Neutral / worth noting (1)

Shilpa Medicare Limited has submitted to the Exchange, the financial results for the period ended September 30, 2026.

NSE · Outcome of Board Meeting·5 Nov · 2d ago

(opens in new tab)
Weighs against the BUY call (0)

Nothing found in this tip’s window yet.

Factor classifications are AI-generated from exchange filings, verified news feeds and market data — they can be wrong or incomplete, and are not attributed to the issuing analyst. Verify every factor via its linked original before acting. This is not investment advice.

Other calls on Shilpa Medicare

All analyst calls on Shilpa Medicare

More from Prabhudas Lilladher

Every call and its outcome